PubMed چکیده/رکورد

REPRINTED FROM THE 2023 HYPERBARIC INDICATIONS MANUAL 15TH EDITION:Randomized Controlled Trials in Hyperbaric Medicine.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

The criticism has been made of hyperbaric medicine that treatment is based on little or no good clinical evidence. Recently, improved awareness among medical practitioners of the importance of evidence has highlighted this perception, as has the proliferation of both funder-generated reviews and technology assessments [1-3]. In fact, many clinical randomized controlled trials (RCTs) investigating the application of hyperbaric oxygen (HBO₂) therapy have been reported, albeit of variable quality. It is the purpose of this review to describe the place of RCTs within the practice of evidence-based medicine (EBM), summarize the methods by which such trials can be located, discuss the appraisal and performance of RCTs with specific reference to hyperbaric medicine, and to provide a list of RCTs and meta-analyses in hyperbaric medicine to date. Particular reference is made to the work of the Cochrane Collaboration within the field. An appendix provides a comprehensive list of published RCTs and meta-analyses arranged by indication (Appendix 1). To date, this list includes 416 citations of 390 trials.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

[THE TRADITIONAL AND COMPLEMENTARY MEDICINE IN THE PUBLIC HEALTH SYSTEM OF THE RUSSIAN FEDERATION: ANALYSIS OF EVIDENCE BASE AND LEGAL ASPECTS OF INTEGRATION].

The article considers placement of methods of traditional and complementary medicine in the public health system of the Russian Federation, focusing on prevention and management of chronic non-communicable diseases. The analysis of the evidence base on key methods of traditional and complementary medicine (acupuncture, phytotherapy, homeopathy, manual therapy, osteopathy) was carried out, including differentiated estimate of level of e…

PubMed2026

[Chinese expert consensus on the clinical application of lung biopsy in interstitial lung disease].

Interstitial lung disease (ILD) comprises a highly heterogeneous group of pulmonary disorders, whose diagnosis often requires the integration of clinical, radiologic, and pathologic evidence. Lung biopsy is a key method for obtaining a histopathologic diagnosis, but unified standards are lacking for determining indications, selecting biopsy techniques, managing patients perioperatively, and integrating pathologic and clinical informati…

PubMed2026

Targeted US Screening in High-Risk Newborns and Infants: Indications, Techniques, and Disease Findings.

Newborns and infants with certain perinatal exposures, congenital conditions, and genetic syndromes are at increased risk for clinically significant diseases and may benefit from early detection. In these children, imaging serves as a targeted screening tool to identify actionable abnormalities during a window in which intervention may reduce morbidity and long-term sequelae. The authors summarize evidence-based US screening strategies…

PubMed2026

The Promises and Perils of Clinical Decision Support Artificial Intelligence.

Evidence-based clinical decision support artificial intelligence (AI) is rapidly expanding, but its safe and effective use depends on rigorous validation, trustworthy evidence sources and careful integration into clinical workflows. Current available systems show strong potential to improve diagnostic accuracy, reduce clinician workload and possibly benefit patient care, but challenges remain before its real-world adoption. We must be …